Biopharma & Vaccines
![](https://eu-admin.eventscloud.com/file_uploads/264f5ae98682e71b05e62617d04c6880_Maskgroup10.png)
Baseimmune is a discovery stage biotech company developing future-proof antigens for universal vaccines. Baseimmune generates artificial cross protective antigens compatible with any delivery systems such as mRNA, viral vectors.
Visit company site![](https://eu-admin.eventscloud.com/file_uploads/97f4e7dfc6a9a9fa3b5649311df52abb_profile-pic.png)
Ariane Gomes
Chief Scientific Officer & Co-Founder
![](https://eu-admin.eventscloud.com/file_uploads/9f7492830e202acf083996bcab666711_Maskgroup11.png)
Crescendo Biologics is a private, clinical stage immuno-oncology company developing novel, targeted T cell enhancing Humabody® therapeutics based on a unique, patent protected, discovery platform.
Visit company site![](https://eu-admin.eventscloud.com/file_uploads/35bd915c28dcca47441ebcb5f12f4487_profile-pic1.png)
Theodora Harold
CEO
![](https://eu-admin.eventscloud.com/file_uploads/ab61ec45d4c80b34d3401d42bf2d4655_Maskgroup12.png)
Elasmogen develops innovative antibody-like drugs called soloMERs for the treatment of autoimmune inflammatory diseases and cancer.
Visit company site![](https://eu-admin.eventscloud.com/file_uploads/3d5b53c719ca562021e4113b9c59bcd2_profile-pic22.png)
Dr Caroline Barelle
CEO
![](https://eu-admin.eventscloud.com/file_uploads/b113ce0d3122956fc709eb472fe94d88_logo-epitopea.png)
Epitopea are looking to generate therapeutic off-the-shelf cancer vaccines repurposing the mRNA technology that came to prominence in the COVID pandemic, using a new class of tumour-specific antigens.
Visit company site![](https://eu-admin.eventscloud.com/file_uploads/f245ffdd94f2830382d041aee5eed5f8_profile-pic23.png)
Dr Jon Moore
CEO
![](https://eu-admin.eventscloud.com/file_uploads/5bbeec4150db09fa3720e77937033faf_Maskgroup13.png)
Infex acquires, develops and in-licenses innovative therapeutic solutions to the international threat from antimicrobial resistance, and other pandemic infections.
Visit company site![](https://eu-admin.eventscloud.com/file_uploads/542688340831db7b4cd83fbe29f9feb3_profile-pic24.png)
Carl Curran
Business Development Manager
![](https://eu-admin.eventscloud.com/file_uploads/66db1aba63adf7d6ee013ffdc3af6bd3_logo-phaim.png)
Developing novel therapies for the treatment and early detection of autoimmune disease with a lead product in type 1 diabetes.
Visit company site![](https://eu-admin.eventscloud.com/file_uploads/4dca4618608a7300933b5352b2aa0981_profile-pic25.png)
Nara Daubeney
COO & Co-Founder
![](https://eu-admin.eventscloud.com/file_uploads/29fa7b49eb10fb5e4a1719b867561ed2_logo-solascure.png)
Developing proprietary technology leveraging biomimicry and evidence-based medicine to empower health care professionals to treat patients with chronic wounds.
Visit company site![](https://eu-admin.eventscloud.com/file_uploads/56d94f3520a90f58a058b14684827fac_profile-pic2.png)
Sam Bakri
CEO
![](https://eu-admin.eventscloud.com/file_uploads/e6cc69bebb85926db5c004c1ab686de7_logo-synairgen.png)
A specialist respiratory biotech developing and investigating inhaled IFN-β (SNG001) in late-stage clinical trials for the treatment or prevention of severe viral lung infections.
Visit company site![](https://eu-admin.eventscloud.com/file_uploads/f5eeda2b49777e38014dee7b1bbe917b_profile-pic3.png)
Richard Marsden
CEO
Category Winners
See our 2023 Category Winners
Meet our 6 Category Winners selected for being market leading
UK Innovators in life sciences.